blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1414812

EP1414812 - HYDROXAMIC ACID DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.12.2006
Database last updated on 25.09.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR		published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
Celltech R & D Limited
208 Bath Road Slough
Berkshire SL1 3WE / GB
[2006/08]
Former [2004/19]For all designated states
Celltech R & D Limited
208 Bath Road
Slough, Berkshire SL1 3WE / GB
Inventor(s)01 / DYKE, Hazel, Joan, Celltech R & D Limited
208 Bath Road
Slough, Berkshire, SL1 3WE / GB
02 / WATSON, Robert, John, Celltech R & D Limited
208 Bath Road
Slough, Berkshire, SL1 3WE / GB
 [2004/19]
Representative(s)Thompson, John
Celltech R&D Limited Patent Department 208 Bath Road
Slough, Berkshire SL1 3WE / GB
[N/P]
Former [2004/19]Thompson, John
Celltech R&D Limited Patent Deparment 208 Bath Road
Slough, Berkshire SL1 3WE / GB
Application number, filing date02747621.707.08.2002
[2004/19]
WO2002GB03656
Priority number, dateGB2001001939609.08.2001         Original published format: GB 0119396
[2004/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03014101
Date:20.02.2003
Language:EN
[2003/08]
Type: A1 Application with search report 
No.:EP1414812
Date:06.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 20.02.2003 takes the place of the publication of the European patent application.
[2004/19]
Type: B1 Patent specification 
No.:EP1414812
Date:22.02.2006
Language:EN
[2006/08]
Search report(s)International search report - published on:EP20.02.2003
ClassificationIPC:C07D309/08, A61K31/445, A61P35/00
[2004/19]
CPC data not yet available
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/19]
Extension statesAL09.02.2004
LT09.02.2004
LV09.02.2004
MK09.02.2004
RO09.02.2004
SI09.02.2004
TitleGerman:HYDROXAMSÄURE-DERIVATE[2004/19]
English:HYDROXAMIC ACID DERIVATIVES[2004/19]
French:DERIVES D'ACIDE HYDROXAMIQUE[2004/19]
Entry into regional phase09.02.2004National basic fee paid 
09.02.2004Designation fee(s) paid 
09.02.2004Examination fee paid 
Examination procedure06.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.02.2004Examination requested  [2004/19]
24.05.2004Despatch of a communication from the examining division (Time limit: M06)
01.12.2004Reply to a communication from the examining division
05.08.2005Communication of intention to grant the patent
15.12.2005Fee for grant paid
15.12.2005Fee for publishing/printing paid
Opposition(s)23.11.2006No opposition filed within time limit [2007/05]
Fees paidRenewal fee
09.02.2004Renewal fee patent year 03
31.08.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY22.02.2006
CZ22.02.2006
EE22.02.2006
FI22.02.2006
SK22.02.2006
TR22.02.2006
BG22.05.2006
DK22.05.2006
GR23.05.2006
LU07.08.2006
IE08.08.2006
MC31.08.2006
[2009/42]
Former [2009/03]CY22.02.2006
CZ22.02.2006
EE22.02.2006
FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
GR23.05.2006
LU07.08.2006
IE08.08.2006
MC31.08.2006
Former [2008/37]CZ22.02.2006
EE22.02.2006
FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
GR23.05.2006
LU07.08.2006
IE08.08.2006
MC31.08.2006
Former [2008/28]CZ22.02.2006
EE22.02.2006
FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
GR23.05.2006
IE08.08.2006
MC31.08.2006
Former [2008/22]CZ22.02.2006
FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
GR23.05.2006
IE08.08.2006
MC31.08.2006
Former [2008/21]CZ22.02.2006
FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
GR23.05.2006
IE08.08.2006
MC31.08.2006
Former [2007/45]FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
IE08.08.2006
MC31.08.2006
Former [2007/42]FI22.02.2006
IT22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
IE08.08.2006
MC31.08.2006
Former [2007/38]FI22.02.2006
IT22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
MC31.08.2006
Former [2007/19]FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
MC31.08.2006
Former [2007/03]FI22.02.2006
SK22.02.2006
BG22.05.2006
DK22.05.2006
Former [2006/52]FI22.02.2006
BG22.05.2006
DK22.05.2006
Former [2006/48]FI22.02.2006
BG22.05.2006
Former [2006/36]FI22.02.2006
Cited inInternational search[DY]WO9924399  (DARWIN DISCOVERY LTD [GB]) [DY] 1-8 * page 2, line 1 - page 3, line 13; examples 37,39 *;
 [Y]WO0046221  (SEARLE & CO [US], et al) [Y] 1-8 * examples 17,25; claim 11 *;
 [Y]  - BARTA T. E. ET AL., "Synthesis and Activity of Selective MMP Inhibitors with an Aryl Backbone", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20001218), vol. 10, no. 24, pages 2815 - 2817, XP000443235 [Y] 1-8 * page 2815, right hand col., last paragraph and page 2817, left hand col. *
 [PY]  - BARTA, T. E. ET AL, "Selective, orally active MMP inhibitors with an aryl backbone", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001), 11(18), 2481-2483, (20010917), XP002215845 [PY] 1-8 * table 1 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(01)00487-5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.